James Laforce insider trades: Arena Pharmaceuticals (ARNA) stock purchases
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where James reports to the SEC
and 7 more companies
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| May 14, 2009 | ARNA | ↑ Buy | 3,500 | $2.74 | $10K | Direct | May 14, 2009 (0d) |
| May 13, 2008 | ARNA | ↑ Buy | 10,000 | $5.18 | $52K | Direct | May 13, 2008 (0d) |
| Dec 9, 2005 | BDJ | ↑ Buy | 600 | $13.03 | $8K | Direct | Dec 13, 2005 (4d) |
| Dec 9, 2005 | BWC | ↑ Buy | 250 | $14.70 | $4K | Direct | Dec 13, 2005 (4d) |
| Jun 23, 2005 | BOE | ↑ Buy | 200 | $25.01 | $5K | Direct | Jun 27, 2005 (4d) |
| Jun 23, 2005 | HIS | ↑ Buy | 200 | $2.83 | $566 | Direct | Jun 27, 2005 (4d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About James Laforce's insider trades
James Laforce is a director at Arena Pharmaceuticals (ARNA). Since Jun 23, 2005, James has reported 6 open-market purchases worth $78K and no sales on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (48 filings), shares returned to the company (5 filings). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every ARNA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.